Total Payments
$9,597
2024 Payments
$2,692
Companies
47
Transactions
529
Medicare Patients
3,948
Medicare Billing
$325,942
Payment Breakdown by Category
Food & Beverage$8,707 (90.7%)
Education$889.57 (9.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,707 | 515 | 90.7% |
| Education | $889.57 | 14 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $1,423 | 36 | $0 (2024) |
| UCB, Inc. | $1,153 | 57 | $0 (2024) |
| Amgen Inc. | $774.51 | 42 | $0 (2023) |
| ABBVIE INC. | $619.39 | 34 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $532.58 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $488.17 | 28 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $473.23 | 55 | $0 (2022) |
| Lilly USA, LLC | $438.33 | 27 | $0 (2024) |
| SK Life Science, Inc. | $359.81 | 18 | $0 (2024) |
| ARGENX US, INC. | $336.57 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,692 | 135 | Alexion Pharmaceuticals, Inc. ($804.31) |
| 2023 | $1,923 | 98 | Alexion Pharmaceuticals, Inc. ($499.87) |
| 2022 | $867.66 | 61 | Amgen Inc. ($244.96) |
| 2021 | $964.47 | 52 | Amgen Inc. ($176.48) |
| 2020 | $1,304 | 79 | Teva Pharmaceuticals USA, Inc. ($206.44) |
| 2019 | $1,366 | 60 | Novartis Pharmaceuticals Corporation ($175.81) |
| 2018 | $83.56 | 6 | UCB, Inc. ($24.50) |
| 2017 | $396.57 | 38 | Supernus Pharmaceuticals, Inc. ($267.85) |
All Payment Transactions
529 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Neurology | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: PAIN | ||||||
| 12/18/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $3.27 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: Rare Disease | ||||||
| 12/13/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $13.75 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Neurology | ||||||
| 12/09/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $24.70 | General |
| 12/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Neurology | ||||||
| 11/21/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.44 | General |
| 11/21/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Rare Disease | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Neurology | ||||||
| 11/16/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Neurology | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: PAIN | ||||||
| 11/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: Rare Disease | ||||||
| 11/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/30/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Neurology | ||||||
| 10/30/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.43 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Neurology | ||||||
| 10/22/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Neuroscience | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 787 | 830 | $187,901 | $62,296 |
| 2022 | 21 | 1,009 | 1,095 | $238,303 | $87,250 |
| 2021 | 20 | 1,050 | 1,125 | $233,058 | $86,061 |
| 2020 | 22 | 1,102 | 1,230 | $253,508 | $90,335 |
Total Patients
3,948
Total Services
4,280
Medicare Billing
$325,942
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 77 | 77 | $26,026 | $8,623 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 106 | $25,758 | $8,544 | 33.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 114 | 114 | $24,168 | $8,396 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $22,896 | $7,309 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 105 | 124 | $21,328 | $7,303 | 34.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 37 | $12,691 | $4,391 | 34.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 77 | 77 | $10,549 | $3,725 | 35.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 31 | $8,029 | $2,855 | 35.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $6,315 | $2,168 | 34.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 23 | 23 | $4,301 | $1,619 | 37.6% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 35 | 37 | $5,550 | $1,604 | 28.9% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 16 | 16 | $4,144 | $1,325 | 32.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 28 | 30 | $5,160 | $1,173 | 22.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 19 | 19 | $3,648 | $1,167 | 32.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 14 | $1,918 | $834.82 | 43.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 26 | $2,756 | $755.55 | 27.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 12 | 12 | $2,664 | $502.57 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 120 | $25,839 | $10,162 | 39.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 98 | 99 | $25,839 | $9,706 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 149 | $22,128 | $8,765 | 39.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $21,502 | $8,047 | 37.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 49 | 49 | $17,552 | $6,219 | 35.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 33 | 33 | $13,053 | $5,324 | 40.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 39 | 42 | $11,816 | $5,057 | 42.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 61 | 61 | $12,462 | $4,488 | 36.0% |
About Dr. Joseph Oropilla, MD
Dr. Joseph Oropilla, MD is a Neurology healthcare provider based in Elizabethtown, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790792406.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Oropilla, MD has received a total of $9,597 in payments from pharmaceutical and medical device companies, with $2,692 received in 2024. These payments were reported across 529 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($8,707).
As a Medicare-enrolled provider, Oropilla has provided services to 3,948 Medicare beneficiaries, totaling 4,280 services with total Medicare billing of $325,942. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Elizabethtown, KY
- Active Since 08/02/2006
- Last Updated 07/30/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1790792406
Products in Payments
- Aimovig (Biological) $774.51
- ULTOMIRIS (Biological) $726.83
- NURTEC ODT (Drug) $539.38
- Briviact (Drug) $486.88
- TROKENDI XR (Drug) $385.32
- Nayzilam (Drug) $351.31
- EMGALITY (Drug) $347.01
- VYVGART (Drug) $311.47
- UBRELVY (Drug) $266.45
- AJOVY (Biological) $227.34
- BOTOX (Biological) $212.14
- KESIMPTA (Drug) $195.91
- Xadago (Drug) $178.27
- TYSABRI (Biological) $174.25
- DUOPA (Drug) $164.91
- Leqembi (Drug) $160.28
- MAYZENT (Drug) $149.93
- VNS Therapy (Device) $143.69
- APOKYN (Drug) $133.67
- Rystiggo (Drug) $131.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.